Thymosin Alpha-1: Immunomodulatory Peptide Research Overview

Thymosin Alpha-1: Immunomodulatory Peptide Research Overview

Thymosin Alpha-1 (Tα1) is a 28 amino acid peptide first isolated from thymosin fraction 5 by Allan Goldstein in the 1970s. It has since become one of the most studied immunomodulatory peptides.

Mechanism of Action

Tα1 acts primarily by stimulating T-lymphocyte differentiation, maturation, and function. Research has demonstrated effects on dendritic cell activation, natural killer cell activity, and cytokine production modulation.

Research Applications

Published research has explored Tα1 in the context of antiviral immunity, autoimmune disease modulation, and immunodeficiency states. It has been commercially approved in some countries for specific clinical applications, which validates the robustness of the underlying research.